Company lists · Data refreshed September 2026

Top 18 Immunotherapy venture capital companies based in South San Francisco, United States

RevenueBase identified 28 immunotherapy venture capital companies headquartered in South San Francisco, United States as of September 2026 and tracks 2,179 professional contacts across them, including 980 with verified work emails. Cambridge is the largest hub.

This list covers immunotherapy venture capital companies headquartered in South San Francisco, United States, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, how directly it supports the match, and when it was last checked. Data refreshed September 3, 2026.

Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase SmartSearch, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.

How to read this list HQ checked on every row Match evidence on every row Refreshed Sep 3, 2026 86% judged on-target in blind review
28Companies
2,179Contacts tracked
980Verified emails
Unlock all 28 companies Free signup · no credit card · 500 free credits

The 18 largest immunotherapy venture capital companies based in South San Francisco, United States

Ranked by team size
Top 18 of 28 immunotherapy venture capital companies based in South San Francisco, United States, ranked by team size, largest first. Data refreshed Sep 3, 2026. Evidence rates how directly each company's own description names immunotherapy venture capital companies: strong (names it), partial (names part of it), indirect (matched on its full profile rather than the summary shown). Click a count to unlock that company's people.
#CompanyHeadquartersEmployeesContacts
1
Lyell ImmunopharmaIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 2026201-500212

“Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer.”

Source: company website · checked Sep 3, 2026
2
AlumisIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202611-50124

“At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.”

Source: company website · checked Sep 3, 2026
3
Rapt TherapeuticsIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202651-200123

“RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory…”

Source: company website · checked Sep 3, 2026
4
Pionyr ImmunotherapeuticsPartial evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202651-20067

“In 2015, Pionyr Immunotherapeutics embarked on a journey to forge a new path in immuno-oncology for patients in need.”

Source: company website · checked Sep 3, 2026
5
ALX OncologyIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202651-20057

“ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives.”

Source: company website · checked Sep 3, 2026
6
3t BiosciencesPartial evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202611-5031

“3T is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient…”

Source: company website · checked Sep 3, 2026
7
Atreca, INCIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202651-20029

“Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer…”

Source: company website · checked Sep 3, 2026
8
Calithera BiosciencesIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202651-20028

“Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to…”

Source: company website · checked Sep 3, 2026
9
Link Cell TherapiesPartial evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202611-5027

“Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with investors Samsara BioCapital and Sheatree Capital.”

Source: company website · checked Sep 3, 2026
10
Tizona Therapeutics, INCIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202611-5022

“Tizona Therapeutics, Inc, is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases.”

Source: company website · checked Sep 3, 2026
11
Pact PharmaIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202611-5019

“At PACT Pharma, our vision is to create potentially curative T cell therapies for solid cancers that are tailored for each and every patient.”

Source: company website · checked Sep 3, 2026
12
Cero Therapeutics, INCIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202611-5015

“At CERo, we are expanding the armamentarium of engineered cell therapies to create a whole new class of innovative medicines for oncology.”

Source: company website · checked Sep 3, 2026
13
Qlsf Biotherapeutics, INCIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202611-5012

“QLSF Biotherapeutics is an innovative immuno-oncology biotech startup in South San Francisco.”

Source: company website · checked Sep 3, 2026
14
Harpoon TherapeuticsIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 202651-20011

“Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients…”

Source: company website · checked Sep 3, 2026
15
Tegmine Therapeutics, INCIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 20261-107

“At Tegmine we target glycoproteins, which are a hallmark of numerous solid cancers and drive aggressive disease.”

Source: company website · checked Sep 3, 2026
16
Iggenix, INCPartial evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 20261-107

“IgGenix is a clinical-stage, venture backed biotechnology company founded on breakthrough advances in Steve Quake’s laboratory at Stanford in collaboration with allergy clinician…”

Source: company website · checked Sep 3, 2026
17
Primevax Immuno-OncologyIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 20261-104

“PrimeVax Immuno-Oncology, Inc.”

Source: company website · checked Sep 3, 2026
18
Ascensus Therapeutics, INCIndirect evidence
South San Francisco, CA, United StatesHQ checked Sep 3, 20261-102

“A clinical stage biotechnology company developing synthetic biology platform company developing a new technology for directly modulating cytokine signaling pathways in health and…”

Source: company website · checked Sep 3, 2026

Showing 18 of 28 immunotherapy venture capital companies based in South San Francisco, United States

See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 980 reachable decision-makers.

Free signup · no credit card

See all 28 companies

Immunotherapy venture capital companies based in South San Francisco, United States at a glance

As of Sep 3, 2026
11-50Median size (employees)
CambridgeLargest hub · 50 HQs
Contacts with mobile numbers
Sep 3, 2026Data refreshed

Companies by employee count

1-10
7
11-50
10
51-200
8
201-500
1
501-1,000
1
1,001-5,000
1

Email recency for this list is measured across the whole United States list rather than this city, so it is reported there. Company counts and contact totals on this page are exact for South San Francisco, over 28 companies.

How this list was built

Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among immunotherapy venture capital companies, so some rows will be adjacent to the category rather than pure plays. The description and evidence rating on every row are there so you can check each match yourself.

Source
The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase SmartSearch, the natural-language company search available to every RevenueBase user.
What qualifies
Companies headquartered in South San Francisco, United States whose own description of what they do matches “immunotherapy venture capital companies”. Matching reads each company's description, not its industry code or its name.
What we exclude
Companies whose own description does not clearly place them among immunotherapy venture capital companies, and records with no verified work email. Companies headquartered outside South San Francisco are excluded even when they keep an office there.
Match quality
In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and an evidence rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
Ranking
Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
Verification
Every listed company carries at least one verified work email, 980 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
Refresh
This page's figures were pulled from the company graph on September 3, 2026. Lists refresh periodically as the graph is re-checked.
Corrections
Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.

Frequently asked

How many immunotherapy venture capital companies are there based in South San Francisco, United States?

RevenueBase identified 28 immunotherapy venture capital companies headquartered in South San Francisco, United States as of September 2026, matched on each company's own description of what it does rather than its industry code.

What is the largest company on this list?

Lyell Immunopharma, headquartered in South San Francisco, tops this list with the largest team on record.

Which city has the most immunotherapy venture capital companies?

Cambridge leads with 50 headquartered companies, followed by San Diego (49) and Boston (39).

How do I get contact information for these companies?

A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 980 verified decision-maker contacts tracked across these 28 companies.

How current is this list?

The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 3, 2026.

Ready to reach these companies? Verified emails and direct dials for all 28 immunotherapy venture capital companies based in South San Francisco, United States. Start with a free account, no credit card.

Get the full list

Related lists

About this data

RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase SmartSearch, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.